These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3161908)
41. Analysis of the negative allogeneic effect using B cells and helper T cell lines as an indicator system: B cells identified as target cells for suppression. Vöhringer V; Schimpl A; Hünig T J Immunol; 1985 Apr; 134(4):2090-9. PubMed ID: 3156179 [TBL] [Abstract][Full Text] [Related]
42. The induction of a unique procoagulant activity in rabbit hepatic macrophages by bacterial lipopolysaccharides. Maier RV; Ulevitch RJ J Immunol; 1981 Oct; 127(4):1596-600. PubMed ID: 7024410 [TBL] [Abstract][Full Text] [Related]
43. The procoagulant potential of environmental particles (PM10). Gilmour PS; Morrison ER; Vickers MA; Ford I; Ludlam CA; Greaves M; Donaldson K; MacNee W Occup Environ Med; 2005 Mar; 62(3):164-71. PubMed ID: 15723881 [TBL] [Abstract][Full Text] [Related]
44. Expression of procoagulant activity in a human monocyte-like cell line. Ewan VA; Edwards RL; Rickles FR J Lab Clin Med; 1983 Mar; 101(3):401-10. PubMed ID: 6338139 [TBL] [Abstract][Full Text] [Related]
45. Production and characterization of a monoclonal antibody (A1-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity. Ewan VA; Cieplinski W; Hancock WW; Goldschneider I; Boyd AW; Rickles FR J Immunol; 1986 Apr; 136(7):2408-15. PubMed ID: 3950416 [TBL] [Abstract][Full Text] [Related]
46. Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients. Salomao R; Brunialti MK; Kallás EG; Martins PS; Rigato O; Freudenberg M J Endotoxin Res; 2002; 8(5):371-9. PubMed ID: 12537696 [TBL] [Abstract][Full Text] [Related]
47. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model. Wang B; Wu SM; Wang T; Liu K; Zhang G; Zhang XQ; Yu JH; Liu CZ; Fang CC Chin Med J (Engl); 2012 May; 125(10):1753-9. PubMed ID: 22800895 [TBL] [Abstract][Full Text] [Related]
48. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. Blanchard DK; Djeu JY; Klein TW; Friedman H; Stewart WE J Immunol; 1986 Feb; 136(3):963-70. PubMed ID: 2867114 [TBL] [Abstract][Full Text] [Related]
49. Optimization of conditions for in vitro production of radical oxygen species and expression of tissue factor by canine mononuclear cells and granulocytes for use in high-throughput assays. Okano S; Hurley DJ; Bergh MS; Vandenplas ML; Budsberg SC; Moore JN Vet Immunol Immunopathol; 2006 Aug; 112(3-4):234-42. PubMed ID: 16750570 [TBL] [Abstract][Full Text] [Related]
50. In vitro induction of anti-thyroid microsomal antibody-secreting cells in peripheral blood mononuclear cells from normal subjects. Iitaka M; Aguayo JF; Iwatani Y; Row VV; Volpé R J Clin Endocrinol Metab; 1988 Oct; 67(4):749-54. PubMed ID: 2971081 [TBL] [Abstract][Full Text] [Related]
51. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study. McGee MP; Wallin R; Wheeler FB; Rothberger H Blood; 1989 Oct; 74(5):1583-90. PubMed ID: 2790188 [TBL] [Abstract][Full Text] [Related]
52. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. Maimone D; Reder AT; Gregory S Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234 [TBL] [Abstract][Full Text] [Related]
53. Effects of tacrolimus hydrate (FK-506) on the expression of tissue factor in THP-1 human monocyte cell line. Zaman AK Hokkaido Igaku Zasshi; 2000 May; 75(3):179-86. PubMed ID: 10884973 [TBL] [Abstract][Full Text] [Related]
54. Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Walsh J; Wheeler HR; Geczy CL Br J Haematol; 1992 Aug; 81(4):480-8. PubMed ID: 1390232 [TBL] [Abstract][Full Text] [Related]
55. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. Mattern T; Flad HD; Brade L; Rietschel ET; Ulmer AJ J Immunol; 1998 Apr; 160(7):3412-8. PubMed ID: 9531301 [TBL] [Abstract][Full Text] [Related]
56. Lymphokine-induced monocyte procoagulant activity is depressed in patients with advanced malignancies. Geczy CL; Ryan J; Walsh J; Goldstein D Int J Cancer; 1986 May; 37(5):677-82. PubMed ID: 3699930 [TBL] [Abstract][Full Text] [Related]
57. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. Schwartz BS; Levy GA; Curtiss LK; Fair DS; Edgington TS J Clin Invest; 1981 Jun; 67(6):1650-8. PubMed ID: 7240413 [TBL] [Abstract][Full Text] [Related]
58. Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant. Schved JF; Gris JC; Ollivier V; Wautier JL; Tobelem G; Caen J Am J Hematol; 1992 Oct; 41(2):92-6. PubMed ID: 1415187 [TBL] [Abstract][Full Text] [Related]
59. The effect of serum on monocyte tissue factor generation. Edwards RL; Perla D Blood; 1984 Sep; 64(3):707-14. PubMed ID: 6235870 [TBL] [Abstract][Full Text] [Related]
60. Procoagulant synthesis by exudate and bone marrow-derived murine macrophages. Shands JW; Sunnenberg TD; Lottenberg R J Leukoc Biol; 1988 Sep; 44(3):172-9. PubMed ID: 3411233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]